Dominant monoallelic variant in the PAK2 gene causes Knobloch syndrome type 2HUMAN MOLECULAR GENETICSIF3.22021-03-099OAAI
PROGRESS TOWARD THE CLINICAL APPLICATION OF AUTOLOGOUS INDUCED PLURIPOTENT STEM CELLS AND GENE REPAIR THERAPY FOR TREATMENT OF FAMILIAL HYPERCHOLESTEROLEMIAJOURNAL OF HEPATOLOGYIF332011-03-010PREAI
Ex Vivo Hepatocyte Gene Therapy: Increased Biosafety Protocol for Transduction in Suspension With Lentiviral Vectors and Immediate Transplantation (SLIT)TRANSPLANTATIONIF52010-01-157OAAI
Biosafety in Ex Vivo Gene Therapy and Conditional Ablation of Lentivirally Transduced Hepatocytes in Nonhuman PrimatesMOLECULAR THERAPYIF122009-10-0131OAAI
A Step Toward Liver Gene Therapy: Efficient Correction of the Genetic Defect of Hepatocytes Isolated From a Patient With Crigler-Najjar Syndrome Type 1 With Lentiviral Vectors迈向肝脏基因治疗的一步: 用慢病毒载体有效纠正从1型crigler-najjar综合征患者分离的肝细胞的遗传缺陷TRANSPLANTATIONIF52009-04-1526OAAI
BIOSAFETY IN EX VIVO GENE THERAPY AND CONDITIONAL ABLATION OF LENTIVIRALLY-TRANSDUCED HEPATOCYTES IN NON-HUMAN PRIMATESJOURNAL OF HEPATOLOGYIF332009-04-010OAAI
Mechanisms regulating the proliferative potential of human CD8+ T lymphocytes overexpressing telomeraseJOURNAL OF IMMUNOLOGYIF3.42006-09-1533OAAI
Mechanisms that limit the in vitro proliferative potential of human CD8+ T lymphocytesJOURNAL OF IMMUNOLOGYIF3.42005-03-1528OAAI
How pathogenic is the p.D104N/endostatin polymorphic allele of COL18A1 in Knobloch syndrome?: ReplyHUMAN MUTATIONIF3.72005-01-011OAAI
The Caenorhabditis elegans ortholog of C21orf80, a potential new protein O-fucosyltransferase, is required for normal developmentGENOMICSIF32004-08-0123OAAI
Knobloch syndrome:: Novel mutations in COL18A1, evidence for genetic heterogeneity, and a functionally impaired polymorphism in endostatinHUMAN MUTATIONIF3.72004-01-0185OAAI